Monte Rosa Therapeutics (GLUE) Return on Sales (2024 - 2026)

Monte Rosa Therapeutics (GLUE) posted quarterly Return on Sales of 0.1% for Q1 2026, down 11.0% year-over-year from 0.12% in Q1 2025, and up 2.29% quarter-over-quarter from 0.11% in Q4 2025.

Monte Rosa Therapeutics (GLUE) Return on Sales (2024 - 2026) Analysis & Trends

Monte Rosa Therapeutics' Return on Sales history runs 3 years deep, the most recent figure standing at 0.1% for Q1 2026.

  • In Q1 2026, Return on Sales fell 11.0% year-over-year to 0.1%; the TTM figure through Mar 2026 stood at 0.26% (down 27.0% YoY), while the FY2025 annual figure was 0.0%, up 1.0% from the prior year.
  • Return on Sales for Q1 2026 stood at 0.1%, up from 0.11% in the prior quarter.
  • The five-year high for Return on Sales was 0.01% in Q1 2025, with the low at 0.3% in Q1 2024.
  • The 3-year median for Return on Sales is 0.03% (2024), against an average of 0.07%.
  • Peak annual rise in Return on Sales reached 31 bps in 2025, while the deepest fall reached 11 bps in 2025.
  • Monte Rosa Therapeutics' Return on Sales stood at 0.01% in 2024, then sank by 2192 bps to 0.11% in 2025, then rose by 2 bps to 0.1% in 2026.
  • Business Quant data shows GLUE's Return on Sales at 0.1% in Q1 2026, 0.11% in Q4 2025, and 0.0% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 0.00%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.00%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 0.00%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.00%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 0.00%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.00%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 0.00%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 0.00%
10 Monte Rosa Therapeutics 1.32 Bn 688.11 Mn - -0.05%

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.05%
Mar 31, 2026 -0.10%
Dec 31, 2025 -0.11%
Sep 30, 2025 0.00%
Jun 30, 2025 0.00%
Mar 31, 2025 0.01%
Dec 31, 2024 0.01%
Sep 30, 2024 -0.03%
Jun 30, 2024 -0.06%
Mar 31, 2024 -0.30%